Resources

Publications &
Case Reports.

Selected peer-reviewed papers, published case reports and presentations from our team and collaborators.

Key papers

  1. 2023

    Molecular tumor board discussion:“Molecules” missed to discuss in the tumor board

    Maskomani, Silambarasan

    Cancer Research, Statistics, and Treatment

Guidelines and evidence we follow

Every opinion is grounded in current NCCN, ESMO and ASCO guidance, AMP/ASCO/CAP variant tiers and the published literature.

Clinical evidence